Posterior longitudinal ligament (PLL) in cervical spine is one of the sites of ossification in idiopathic hyperostotic diseases. Although the mechanism of the pathological triggering of the disease has not yet been clarified, the cells in PLL have been reported to express osteotropic cytokines such as BMP-2 and TGF-β. However, it has not been known whether the cells in PLL express receptors for these cytokines. We examined the expression of the messenger RNAs of the genes encoding receptors for BMP-2/4 and TGF-β in the PLL cells. Tissues from three OPLL (ossification of the posterior longitudinal ligament) patients who underwent anterior decompression surgery with removal of the ossified PLL were dissected microscopically and were subjected to explant cultures; the cells outgrown from the explants were examined. Type I BMP receptor (BMPR) mRNA was expressed at moderate levels in the cells derived from both ossifying PLL tissues as well as nonossifying adjacent fibrous tissues. Type II TGF-β receptor (TβR) mRNA and α1(I) collagen mRNA were also constitutively expressed in these PLL cells from either regions. Treatment with BMP-2 enhanced the expression of BMPR mRNA in five out of ten of the cell cultures, suggesting that functional BMP receptors were expressed in at least a part of the PLL cells. The BMP-2 effect on BMPR was specific since no such enhancement was observed with regard to the levels of TβR mRNA in all of the ten cultures. These results indicated for the first time that mRNAs of the genes encoding receptors for BMP-2/4 and TGF-β were expressed in the cells derived from human PLL cells.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/BF02739064 | DOI Listing |
T-cell prolymphocytic leukemia (T-PLL) is an aggressive lymphoid malignancy with limited treatment options. To discover new treatment targets for T-PLL, we performed high-throughput drug sensitivity screening on 30 primary patient samples ex-vivo. After screening over 2'800 unique compounds, we found T-PLL to be more resistant to most drug classes, including chemotherapeutics, compared to other blood cancers.
View Article and Find Full Text PDFPharmaceutics
December 2024
School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China.
Traumatic hemorrhage and infection are major causes of mortality in wounds caused by battlefield injuries, hospital procedures, and traffic accidents. Developing a multifunctional nano-drug capable of simultaneously controlling bleeding, preventing infection, and promoting wound healing is critical. This study aimed to design and evaluate a nanoparticle-based solution to address these challenges effectively.
View Article and Find Full Text PDFHematol Rep
January 2025
Department of 1st Internal Medicine, Medical School, University of Pécs, Ifjúság Str. 13, 7624 Pécs, Hungary.
T-cell prolymphocytic leukemia (T-PLL) is a rare mature T-cell lymphoma that is usually associated with poor prognosis and short overall survival. We present a case of a 61-year-old woman presenting with T-PLL and the leukemic cells harboring (-breakpoint cluster region; -ABL protooncogene 1) fusion transcripts as the result of a variant of t(9;22)(q34;q11) called Philadelphia translocation: t(9;22;18)(q34;q11;q21). Sequencing revealed a rare transcript with an exon 6 breakpoint corresponding to e6a2 transcripts, which has thus far been reported in only 26 cases of leukemias.
View Article and Find Full Text PDFJ Inflamm Res
January 2025
Clinical Medical Center of Tissue Engineering and Regeneration, Xinxiang Medical University, Xinxiang, People's Republic of China.
Purpose: Treatment of severe burn wound injury remains a significant clinical challenge as serious infections/complex repair process and irregulating inflammation response. Human umbilical cord mesenchymal stem cells (hUC-MSCs) have a multidirectional differentiation potential and could repair multiple injuries under appropriate conditions. Poly(L-lysine)-graft-4-hydroxyphenylacetic acid (PLL-g-HPA) hydrogel is an enzyme-promoted biodegradable in hydrogel with good water absorption, biocompatibility and anti-bacterial properties.
View Article and Find Full Text PDFCurr Stem Cell Res Ther
January 2025
University Radiology, Rutgers Robert Wood Johnson Medical School Department of Interventional Radiology New Jersey United States.
Vascular stents and stem cells have been used in high-acuity cases for many decades, particularly in cardiology. Providing the physician with another avenue of treatment, they have had a reasonable amount of success. However, there has been very little research conducted on seeding vascular stents with stem cells when treating intracranial aneurysms.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!